Hyperkalemia clinical trials

Explore recruiting hyperkalemia clinical trials.

Recruiting hyperkalemia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hyperkalemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

InSaKa trial: Insulin dextrose infusion versus nebulized salbutamol versus combination of salbutamol and insulin dextrose in acute hyperkalemia: a randomized clinical trial

France

Therapeutic use (Phase IV) EU CTIS Study details

FINE-START; A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3 study to investigate the efficacy and safety of finerenone versus placebo, in participants with chronic kidney disease not using renin-angiotensin-system inhibitors

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Prospective, Open-Label, Phase IIb/III Study to Evaluate the Risk of TLS and Optimization of the Initiation of Venetoclax in Combination with Obinutuzumab or Acalabrutinib With Different Ramp-Up Periods in Previously Untreated Subjects with CLL

France, Greece, Spain

Phase II and Phase III (Integrated) EU CTIS Study details

An open-label study to assess safety and efficacy of SZC in paediatric patients with hyperkalaemia

Germany, Romania, Spain, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A 2-Part, Open-Label, Phase 2, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer in Children under 12 Years of Age with Hyperkalaemia (EMERALD2)

Slovakia, Greece, France, Hungary, Belgium, Finland +5 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Sodium zirconium cyclosilicate to allow liberal fruit and vegetable intake for patients with CKD stage 3b and 4 (LIBERAL study)

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hyperkalemia trials by city

Hyperkalemia in Toronto Hyperkalemia in Vancouver Hyperkalemia in Montreal Hyperkalemia in Calgary Hyperkalemia in Edmonton Hyperkalemia in Ottawa Hyperkalemia in Winnipeg Hyperkalemia in Quebec City Hyperkalemia in Hamilton Hyperkalemia in Kitchener Hyperkalemia in London Hyperkalemia in Halifax Hyperkalemia in New York Hyperkalemia in Los Angeles Hyperkalemia in Chicago Hyperkalemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease